Lipigo A 150 mg

Composition of Lipigo A 150 mg

Lipigo A 150 mg contains Fenofibrate 150 mg (as Fenofibrate) tablet/capsule. It belongs to the Fibrate (PPAR-alpha agonist) class of medicines.

Uses of Lipigo A 150 mg

• Treatment of high cholesterol and high triglycerides (dyslipidaemia
• hypertriglyceridaemia); used to reduce risk of pancreatitis in severe hypertriglyceridaemia; adjunct to diet and lifestyle changes

Key benefits

• Lowers triglycerides
• Reduces LDL/VLDL
• Raises HDL cholesterol
• Helps control mixed dyslipidaemia
• Reduces pancreatitis risk in severe hypertriglyceridaemia

How Lipigo A 150 mg works

Fenofibrate activates PPAR-α, increasing lipolysis and clearance of triglyceride-rich lipoproteins. It lowers triglycerides and VLDL, can increase HDL, and improves overall lipid profile.

How to take Lipigo A 150 mg

Oral use. Take exactly as prescribed, usually once daily; swallow whole with water. Often taken with food (follow brand/doctor advice). Continue diet, exercise and weight control while on therapy.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take it as soon as you remember. If your next dose is almost due, skip the one you missed — never take two doses together to catch up.

If you take too much

An overdose of this medicine is unlikely to cause immediate harm but may increase the risk of muscle and liver injury. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Lipigo A 150 mg

Most side effects of Lipigo A are mild and settle as the body adjusts. Reported side effects include:

• Stomach pain
• nausea
• diarrhoea
• headache
• dizziness
• elevated liver enzymes
• muscle pain/weakness
• rash

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Lipigo A 150 mg

Warnings and precautions

Not for use in severe kidney disease, active liver disease, gallbladder disease, or known hypersensitivity. Risk of myopathy/rhabdomyolysis increases with statins, in elderly, diabetes, hypothyroidism, or renal impairment—report unexplained muscle pain, tenderness or weakness. Monitor liver function and kidney function periodically. May increase risk of gallstones; stop if pancreatitis is suspected. Dose adjustment/avoid in renal impairment.

Do not take Lipigo A if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Must not be used in pregnancy or while breastfeeding. Not for people with active liver disease.

Interactions with other medicines

Statins (increased myopathy risk), Warfarin/other anticoagulants (increased bleeding—monitor INR), Cyclosporine/tacrolimus (renal risk), Bile acid sequestrants like cholestyramine/colestipol (reduced absorption—separate dosing), Colchicine (myopathy risk)

How to store Lipigo A 150 mg

Store below 25°C in a dry place, protected from light and moisture. Keep out of reach of children.

Expert advice for Lipigo A 150 mg

Continue your diet, exercise and, above all, stopping smoking — the medicine adds to these, not replaces them. Get your lipid profile repeated as your doctor advises.

Manufacturer and class

Manufacturer:

MERCK PHARMA

Therapeutic class:

Antihyperlipidemic

Drug class:

Fibrate (PPAR-alpha agonist)